Each medicine in a case gets a role (E2B(R3) G.k.1):
- Suspect: the reporter or the company suspects it caused the event.
- Concomitant: taken at the same time, not suspected. Medicines given to treat the reaction are not entered as concomitant drugs on the CIOMS form.
- Interacting: suspected of causing the event together with another product. Interacting products count as suspect.
- Drug not administered: the E2B(R3) guide gives two uses. In a clinical trial, an event after the subject signed consent but before the first dose of study drug (screening or washout). In a medication error, the prescribed drug the patient never received; the drug actually dispensed is the suspect.
What happened when the drug was stopped and restarted is key evidence:
- Dechallenge: the drug is stopped or the dose reduced. A positive dechallenge means the reaction went away or improved. The case records the action taken with the drug (G.k.8: withdrawn, dose reduced, dose increased, dose not changed, unknown, not applicable).
- Rechallenge: the drug is given again. A positive rechallenge means the reaction came back. E2B(R3) G.k.9.i.4 records whether a rechallenge was done and its result: yes-yes (recurred), yes-no (did not recur), yes-unknown, or no rechallenge.